Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVUMENIB vs RIBAVIRIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVUMENIB vs RIBAVIRIN: Safety Overview

Metric REVUMENIB RIBAVIRIN
Total FAERS Reports 371 43,397
Deaths Reported 49 2,494
Death Rate 13.2% 5.7%
Hospitalizations 93 8,495
Average Patient Age 46.4 yrs 55.7 yrs
% Female Patients 47.6% 44.3%
FDA Approval Date Nov 15, 2024 Apr 18, 2008
Manufacturer Syndax Pharmaceuticals, Inc. Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued